Medical Devices
-
Recor Medical ex-CEO Lara Barghout joins Medtronic
Barghout, who led Recor when it won FDA approval of the first renal denervation treatment for hypertension, is the new president of Medtronic’s Interventional Cardiology Therapies business.
By Susan Kelly • Sept. 16, 2026 -
CMS expands ACCESS pilot to boost use of digital health tech
The CMS is expanding the number of covered conditions under the program to include heart failure, COPD, substance use disorders and tobacco cessation.
By Elise Reuter • Sept. 16, 2026 -
Explore the Trendlineâž”
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
J&J sells Laminar LAA closure assets it bought 3 years ago
The decision is part of J&J’s strategy to prioritize resources for the greatest impact and positions Laminar for success under dedicated ownership, a spokesperson said.
By Susan Kelly • Sept. 16, 2026 -
Dexcom gives CFO Jereme Sylvain expanded role
Sylvain will work as chief operating officer of the diabetes technology company while continuing as its CFO.
By Nick Paul Taylor • Sept. 16, 2026 -
OIG urges crackdown on equipment suppliers in Medicare Advantage
The agency says the CMS and MA organizations aren’t doing enough to screen durable medical equipment providers, especially out-of-network companies that aren’t enrolled in Medicare.
By Eric Wicklund • Sept. 15, 2026 -
Intuitive single-port robot earns CE mark for new indication
Gaining authorization for transvaginal gynecologic procedures expands the list of indications for da Vinci SP in Europe.
By Nick Paul Taylor • Sept. 15, 2026 -
Beta Bionics’ insulin patch pump gets FDA nod
By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.
By Elise Reuter • Sept. 14, 2026 -
Zimmer proposes to cut 580 jobs in Switzerland
Reducing headcount at the Swiss site is part of an ongoing effort to simplify the company’s manufacturing footprint and supply chain.
By Nick Paul Taylor • Sept. 14, 2026 -
STAAR Surgical hires former CEO to lead commercial team
David Bailey has rejoined STAAR after participating in the successful campaign to block Alcon’s takeover of the company.
By Nick Paul Taylor • Sept. 11, 2026 -
CMS expands TAVR Medicare coverage to asymptomatic patients
The Centers for Medicare and Medicaid Services’ policy update extends Medicare coverage to severe aortic stenosis patients without symptoms, a change that analysts said will especially benefit Edwards Lifesciences.
By Susan Kelly • Sept. 11, 2026 -
Stryker stock falls on slower peripheral vascular, hip sales
CFO Preston Wells said at a healthcare conference that the company is still working through supply issues in its peripheral vascular business and had fewer hip sales than expected so far this quarter.
By Elise Reuter • Sept. 10, 2026 -
Axogen to buy BioCircuit Technologies for $200M
Analysts called the acquisition a good fit for Axogen but said the company’s plans to finance the deal with a public stock offering could be a point of contention for investors.
By Susan Kelly • Sept. 10, 2026 -
Zimmer restructures Americas leadership team
The company promoted three executives and eliminated a fourth position as part of changes intended to support its ongoing commercial transformation.
By Nick Paul Taylor • Sept. 10, 2026 -
Abbott wins FDA approval for dual-energy ablation catheter
CEO Robert Ford has said the atrial fibrillation treatment, along with the company's Volt PFA device, is expected to help Abbott regain market share in electrophysiology.
By Susan Kelly • Sept. 8, 2026 -
Boston Scientific recall of spinal cord stimulator leads tied to more than 1,000 injuries
A problem with the leads could cause inadequate stimulation, Boston Scientific said. In the worst case, leads may need to be removed or replaced.
By Susan Kelly • Sept. 4, 2026 -
Vara receives CE mark for first autonomous breast cancer screening
The AI-enabled device can report screenings it determines are normal without radiologist review.
By Elise Reuter • Sept. 4, 2026 -
Abbott ablation device effective at 1 year in complex cases
Abbott said it will use the study results to secure FDA approval for the TactiFlex Duo catheter that offers both PFA and RF energy for tailoring treatment of atrial fibrillation.
By Susan Kelly • Sept. 2, 2026 -
Enovis inks eCential takeover to develop surgical ortho robots
The orthopedics specialist aims to launch a knee robot in late 2028, followed by a shoulder robot in 2029.
By Nick Paul Taylor • Sept. 2, 2026 -
Medtronic invests $700M in Cornerstone Robotics
Medtronic will gain rights to distribute the Hong Kong-based company’s Sentire surgical robot in certain markets outside the U.S. alongside its own Hugo system.
By Susan Kelly • Sept. 2, 2026 -
Stryker to add rotator cuff repair tech with ZuriMED buy
Rotator cuff augmentation is one of the fastest-growing areas in sports medicine, according to Stryker.
By Elise Reuter • Sept. 1, 2026 -
GE HealthCare secures CE mark for photon-counting CT device
GE HealthCare is challenging Siemens Healthineers in the market for a technology that is designed to provide clearer images than traditional CT systems.
By Nick Paul Taylor • Sept. 1, 2026 -
Boston Scientific discontinues angiographic catheters
The company plans to stop selling its Imager II Angiographic Catheters after a manufacturing problem led the company to pull the devices from the market.
By Elise Reuter • Updated Aug. 31, 2026 -
Kardium receives $31M investment from Canada for manufacturing expansion
The company received FDA approval for its pulsed field ablation system last year and closed a $250 million funding round.
By Nick Paul Taylor • Aug. 31, 2026 -
Medtronic recalls pH monitoring capsule linked to 184 serious injuries
For the second time in two years, Medtronic has pulled capsules from the market over a fault that could obstruct patients’ airways.
By Nick Paul Taylor • Aug. 28, 2026 -
Abbott wins CE mark for new LAA closure device
Abbott is aiming to capture share from Boston Scientific in the market for devices that seal the heart’s left atrial appendage to reduce stroke risk.
By Susan Kelly • Aug. 28, 2026